{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:47:30Z","timestamp":1720140450034},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.jpba.2012.03.011","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T16:13:04Z","timestamp":1331914384000},"page":"352-355","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A single serum dilution enzyme-linked immunosorbent assay for determining anti-human papillomavirus (HPV) antibody titres in humans immunised with prophylactic HPV vaccines"],"prefix":"10.1016","volume":"66","author":[{"given":"Yingji","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoung Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga Won","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young","family":"Tae Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don Yong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2012.03.011_bib0005","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.ygyno.2010.04.003","article-title":"Measuring serum antibody to human papillomavirus following infection or vaccination","volume":"118","author":"Frazer","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jpba.2012.03.011_bib0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.vaccine.2008.10.062","volume":"27","author":"Ferguson","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jpba.2012.03.011_bib0015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1055-9965.EPI-03-0166","article-title":"Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica","volume":"13","author":"Viscidi","year":"2004","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jpba.2012.03.011_bib0020","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s12325-009-0079-5","article-title":"Clinical update of the AS04-adjuvanted human papillomavirus-16\/18 cervical cancer vaccine","volume":"26","author":"Schwarz","year":"2009","journal-title":"Cervarix Adv. Ther."},{"issue":"Suppl. 3","key":"10.1016\/j.jpba.2012.03.011_bib0025","article-title":"Chapter 12: prophylactic HPV vaccines: underlying mechanisms","volume":"24","author":"Stanley","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jpba.2012.03.011_bib0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vaccine.2007.10.064","article-title":"Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines","volume":"26","author":"Miura","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jpba.2012.03.011_bib0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pep.2009.08.005","article-title":"One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae","volume":"70","author":"Kim","year":"2010","journal-title":"Protein Exp. Purif."},{"key":"10.1016\/j.jpba.2012.03.011_bib0040","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s12272-009-1706-z","article-title":"Human papillomavirus 16 and 18 L1 serology in Korean women with high-grade cervical intraepithelial neoplasia and cervical cancer","volume":"32","author":"Jeong","year":"2009","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jpba.2012.03.011_bib0045","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12272-009-1311-1","article-title":"Serologic response to human papillomavirus type 16 virus-like particles in Korean women with cervical precancerous and cancerous lesions","volume":"32","author":"Jeong","year":"2009","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jpba.2012.03.011_bib0050","first-page":"1","article-title":"A new reverse phase HPLC method with fluorescent detection for the determination of salbutamol sulfate in human plasma","volume":"23","author":"Murtaza","year":"2009","journal-title":"B. Chem. Soc. Ethiopia"},{"key":"10.1016\/j.jpba.2012.03.011_bib0055","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/pmic.200300534","article-title":"Overcoming technical variation and biological variation in quantitative proteomics","volume":"3","author":"Molloy","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.jpba.2012.03.011_bib0060","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2012.03.011_bib0065","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JCM.00844-09","article-title":"Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for diagnosis of human papillomavirus infection","volume":"48","author":"Ramanakumar","year":"2010","journal-title":"J. Clin. Microbiol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708512001343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708512001343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T02:55:54Z","timestamp":1543114554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708512001343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":13,"alternative-id":["S0731708512001343"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2012.03.011","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}